Biltmore Family Office LLC Sells 125 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Biltmore Family Office LLC decreased its position in iShares Biotechnology ETF (NASDAQ:IBB) by 1.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,040 shares of the financial services provider’s stock after selling 125 shares during the period. Biltmore Family Office LLC’s holdings in iShares Biotechnology ETF were worth $1,316,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Jane Street Group LLC acquired a new stake in shares of iShares Biotechnology ETF in the 1st quarter valued at approximately $14,386,000. Cetera Investment Advisers raised its holdings in iShares Biotechnology ETF by 689.4% in the first quarter. Cetera Investment Advisers now owns 91,078 shares of the financial services provider’s stock worth $12,498,000 after purchasing an additional 79,541 shares during the period. State of Michigan Retirement System raised its holdings in iShares Biotechnology ETF by 150.0% in the second quarter. State of Michigan Retirement System now owns 125,000 shares of the financial services provider’s stock worth $17,158,000 after purchasing an additional 75,000 shares during the period. Aristides Capital LLC acquired a new position in shares of iShares Biotechnology ETF in the 2nd quarter valued at $9,180,000. Finally, Sanctuary Advisors LLC bought a new stake in shares of iShares Biotechnology ETF in the 2nd quarter valued at $8,118,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Up 0.9 %

Shares of iShares Biotechnology ETF stock opened at $136.10 on Friday. The stock’s fifty day simple moving average is $143.63 and its 200 day simple moving average is $141.71. iShares Biotechnology ETF has a 12 month low of $117.28 and a 12 month high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The firm also recently disclosed a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were given a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.